Clostridium Butyricum for stricturing Crohn's disease
Part of Digestive system clinical trials.
This trial tests a bacteria called Clostridium butyricum to see if it can help people with a type of Crohn's disease that causes narrowing in the right colon or ileocecal area. It may offer a new option for those not on strong immune-suppressing medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn's disease that causes narrowing (stricturing) in the right colon or ileocecal region
- You are between 18 and 85 years old
- You are not taking any immune-suppressing drugs, biologics, or steroids for Crohn's
- You are either on no specific treatment or only taking mesalazine or sulfasalazine
- You have a scheduled colonoscopy with biopsies for your routine care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether taking a daily cranberry supplement can improve gut health and quality of life in people with Crohn's disease. It may help those whose current treatment is stable but still have bothersome symptoms.
This study tests a medicine called tirzepatide to see if it can help people with active Crohn’s disease who have not responded to multiple prior treatments. It focuses on how the drug might work beyond just reducing inflammation.
This trial tests whether taking sodium butyrate (a short-chain fatty acid) and a specific probiotic yeast called Kluyveromyces marxianus can help keep ulcerative colitis in remission and prevent flare-ups. You'd need to be in remission (symptom-free with no active inflammation) when you start.
This trial studies whether a probiotic called Clostridium butyricum can help recovery after pancreatic surgery. It is for patients having a Whipple procedure for tumors near the pancreas.
This trial tests a specific probiotic (a type of beneficial bacteria) to see if it can help people with mild to moderate ulcerative colitis by improving the balance of gut microbes. It may be an option if you have not used many advanced treatments before.
This trial tests whether butyrate can help children and teens with mild-to-moderate ulcerative colitis (a long-term bowel inflammation condition). You may be able to join if your symptoms fit the study level and you haven’t recently started other specific ulcerative colitis treatments right before the study begins.
Hear when a new Crohn Disease (CD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.